Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GNS561 in Advanced Liver Cancer
NCT03316222Phase 2Terminated
- Sponsor
- Genoscience Pharma
- Start
- Apr 2018
- Primary completion
- Jan 2021
- Modality
- Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of ezurpimtrostat in hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC), sponsored by Genoscience Pharma. Started Apr 2018; status: terminated.
02
Drugs
ezurpimtrostat
03
Conditions
hepatocellular carcinoma (HCC)intrahepatic cholangiocarcinoma (ICC)
Beyond the preview
Go deeper on NCT03316222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03316222.